Tower Research Capital Trc Has Decreased By $536,400 Its American Express Co (AXP) Position; Halo Technology Holdings (HALO)’s Sentiment Is 1.26

February 21, 2018 - By Peter Erickson

Tower Research Capital Llc Trc decreased American Express Co (AXP) stake by 51.15% reported in 2017Q3 SEC filing. Tower Research Capital Llc Trc sold 5,960 shares as American Express Co (AXP)’s stock declined 3.65%. The Tower Research Capital Llc Trc holds 5,691 shares with $515,000 value, down from 11,651 last quarter. American Express Co now has $84.85B valuation. The stock increased 0.58% or $0.56 during the last trading session, reaching $97.75. About 1.91M shares traded. American Express Company (NYSE:AXP) has risen 22.41% since February 21, 2017 and is uptrending. It has outperformed by 5.71% the S&P500.

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes and other drug candidates in the United States, Switzerland, and internationally. The company has market cap of $2.75 billion. The companyÂ’s human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. It currently has negative earnings. The Company’s products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids.

Third Security Llc holds 19.28% of its portfolio in Halozyme Therapeutics, Inc. for 17.59 million shares. Senzar Asset Management Llc owns 3.83 million shares or 16.24% of their US portfolio. Moreover, Bb Biotech Ag has 4.15% invested in the company for 8.63 million shares. The Minnesota-based First Light Asset Management Llc has invested 2.45% in the stock. Snyder Capital Management L P, a California-based fund reported 2.47 million shares.

The stock increased 5.52% or $1.02 during the last trading session, reaching $19.5. About 1.35 million shares traded or 9.34% up from the average. Halozyme Therapeutics, Inc. (HALO) has risen 44.89% since February 21, 2017 and is uptrending. It has outperformed by 28.19% the S&P500.

Investors sentiment increased to 0.83 in 2017 Q3. Its up 0.01, from 0.82 in 2017Q2. It increased, as 47 investors sold AXP shares while 434 reduced holdings. 100 funds opened positions while 297 raised stakes. 709.03 million shares or 0.92% less from 715.61 million shares in 2017Q2 were reported. Foster Dykema Cabot & Company Inc Ma reported 11,792 shares. Dupont Mngmt owns 16,201 shares. Brookstone Capital invested 0.02% in American Express Company (NYSE:AXP). Palisade Asset owns 0.14% invested in American Express Company (NYSE:AXP) for 8,447 shares. Arrowstreet Cap Lp accumulated 0.41% or 1.70 million shares. 378,300 are held by Adams Diversified Equity Fund. Meritage Portfolio Mngmt holds 0.03% or 2,864 shares. Rafferty Asset Mgmt Lc reported 122,823 shares stake. South Dakota Council owns 43,580 shares. Qs Invsts Ltd Llc holds 43,346 shares or 0.03% of its portfolio. Boyar Asset Mngmt owns 6,319 shares. Tower Rech Cap Ltd Liability Corporation (Trc) invested in 0.04% or 5,691 shares. Davis Cap Prtn Limited Liability Company accumulated 700,000 shares. Duncker Streett reported 0.15% stake. Old Mutual Customised Solutions (Proprietary) Ltd stated it has 0.37% in American Express Company (NYSE:AXP).

Analysts await American Express Company (NYSE:AXP) to report earnings on April, 18. They expect $1.71 earnings per share, up 27.61% or $0.37 from last year’s $1.34 per share. AXP’s profit will be $1.48 billion for 14.29 P/E if the $1.71 EPS becomes a reality. After $1.58 actual earnings per share reported by American Express Company for the previous quarter, Wall Street now forecasts 8.23% EPS growth.

Among 36 analysts covering American Express Company (NYSE:AXP), 11 have Buy rating, 4 Sell and 21 Hold. Therefore 31% are positive. American Express Company had 107 analyst reports since July 23, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Hold” rating and $84.0 target in Wednesday, August 23 report. The stock of American Express Company (NYSE:AXP) has “Equal-Weight” rating given on Thursday, October 19 by Morgan Stanley. Deutsche Bank maintained American Express Company (NYSE:AXP) rating on Tuesday, February 9. Deutsche Bank has “Buy” rating and $66 target. The rating was maintained by Morgan Stanley on Friday, February 2 with “Equal-Weight”. The rating was maintained by UBS with “Sell” on Friday, January 22. The company was upgraded on Monday, January 30 by Keefe Bruyette & Woods. The stock of American Express Company (NYSE:AXP) earned “Sell” rating by Credit Suisse on Wednesday, January 17. As per Friday, January 12, the company rating was downgraded by J.P. Morgan. Stephens upgraded the stock to “Equal Weight” rating in Tuesday, June 20 report. Goldman Sachs downgraded the shares of AXP in report on Wednesday, January 13 to “Neutral” rating.

Tower Research Capital Llc Trc increased Bank Montreal Que (NYSE:BMO) stake by 19,991 shares to 20,086 valued at $1.90M in 2017Q3. It also upped Bank N S Halifax (NYSE:BNS) stake by 39,478 shares and now owns 39,697 shares. First Tr Exchange Traded Fd (FXO) was raised too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: